Clinical trial finds concurrent therapy not necessary to achieve high pathological in breast cancer
Giving trastuzumab and anthracyclines at the same time is effective at treating HER-2-positive breast cancer, but there is concern that this combination can be associated with an increased risk of cardiac toxicity. New research ...
Nov 13, 2013